New cancer clinical trial: Chemotherapy With Nab-paclitaxel/Germcitabine/Cisplatin +/- BGB324 With Pancreatic Cancer

Published on: August 28, 2018 at 12:00PM
Condition:   Cancer of Pancreas
Interventions:   Drug: BGB324;   Drug: Nab-paclitaxel;   Drug: Gemcitabine;   Drug: Cisplatin
Sponsors:   University of Texas Southwestern Medical Center;   Triligent International;   Translational Genomics Research Institute;   BerGenBio ASA
Not yet recruiting
https://ift.tt/2PgvNuF